Fund Holdings — Kynam Capital Management, LP

Total Portfolio Value:
$898.92M
Total Bought:
$78.70M
Total Sold:
$175.20M
Net Transaction:
-$96.50M
Notable People:
Kynam Capital Management Gp,
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Natera, Inc.(NTRA)2,400,0002,000,000-400,000$150.34M$182.92M20.35%+$32.58M
Syndax Pharmaceuticals, Inc.(SNDX)5,660,0005,660,0000$122.31M$134.71M14.99%+$12.40M
Celldex Therapeutics, Inc.(CLDX)3,005,9042,900,000-105,904$119.21M$121.71M13.54%+$2.50M
Vera Therapeutics, Inc.CL A(VERA)3,650,3391,526,787-2,123,552$56.14M$65.84M7.32%+$9.69M
Cogent Biosciences, Inc.(COGT)5,854,7668,500,000+2,645,234$34.43M$57.12M6.35%+$22.69M
Dynavax Technologies Corp1,514,3834,239,780+2,725,397$21.17M$52.62M5.85%+$31.44M
Vaxcyte, Inc.(PCVX)1,002,407745,000-257,407$62.95M$50.89M5.66%-$12.06M
Liquidia Corporation(LQDA)2,698,3242,248,324-450,000$32.46M$33.16M3.69%+$701.9K
BioCryst Pharmaceuticals, Inc.(BCRX)4,600,0006,527,491+1,927,491$27.55M$33.16M3.69%+$5.61M
Protagonist Therapeutics Inc2,004,8751,144,242-860,633$45.97M$33.10M3.68%-$12.87M
2seventy Bio Inc5,953,8255,953,8250$25.42M$31.85M3.54%+$6.43M
Wave Life Sciences, Inc.SHS(WVE)3,932,0823,932,0820$19.86M$24.26M2.70%+$4.40M
Travere Therapeutics, Inc.(TVTX)2,000,0002,000,0000$17.98M$15.42M1.72%-$2.56M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)01,625,000+1,625,000$0$14.15M1.57%+$14.15M
Sutro Biopharma, Inc.(STRO)2,001,7272,001,7270$8.59M$11.31M1.26%+$2.72M
Amarin Corp PlcADR12,022,95712,022,9570$10.46M$10.71M1.19%+$250.1K
Tyra Biosciences, Inc.(TYRA)340,190515,190+175,000$4.71M$8.45M0.94%+$3.74M
Burning Rock Biotech LimitedADS(BNR)8,694,4269,640,914+946,488$8.09M$7.02M0.78%-$1.07M
Caribou Biosciences, Inc.(CRBU)1,068,5271,068,5270$6.12M$5.49M0.61%-$630.4K
Acelyrin Inc1,200,000396,379-803,621$8.95M$2.68M0.30%-$6.28M
Viridian Therapeutics, Inc.(VRDN)607,915133,877-474,038$13.24M$2.34M0.26%-$10.90M
Centessa Pharmaceuticals PlcADS442,7040-442,704$3.52M$0—-$3.52M
Immunogen Inc1,422,5030-1,422,503$42.18M$0—-$42.18M
Morphosys AgADS4,234,6850-4,234,685$41.92M$0—-$41.92M
Page 1 of 1
Kynam Capital Management, LP — 13F Holdings — Q1 2024 | TickerTrail